Systems parasitology: Effects of Fasciola hepatica on the neurochemical profile in the rat brain

Molecular Systems Biology

Volumn 6, Issue , 2010, Pages

  Saric, Jasmina ^a,b   Li, Jia V ^a,b   Utzinger, Jürg ^b,c   Wang, Yulan ^d   Keiser, Jennifer ^b,c   Dirnhofer, Stephan ^e   Beckonert, Olaf ^a   Sharabiani, Mansour T A ^a   Fonville, Judith M ^a   Nicholson, Jeremy K ^a   Holmes, Elaine ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d Wuhan National Laboratory for Optoelectronics   (China)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

brain; Fasciola hepatica; immunology; metabolic profiling; nuclear magnetic resonance spectroscopy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ECHINOSTOMA; ECHINOSTOMA CAPRONI; FASCIOLA HEPATICA; FASCIOLIASIS; FECES; FEMALE; HISTOPATHOLOGY; INTESTINE; KIDNEY; LIVER; MATHEMATICAL MODEL; NEUROCHEMISTRY; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SCHISTOSOMA MANSONI; SPLEEN; URINE; ANIMAL; COMPARATIVE STUDY; ENERGY METABOLISM; HOST PARASITE INTERACTION; IMMUNOLOGY; METABOLISM; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARASITOLOGY; PATHOGENICITY; PHENOTYPE; STATISTICAL MODEL; SYSTEMS BIOLOGY; TIME; WISTAR RAT;

ECHINOSTOMA CAPRONI; FASCIOLA HEPATICA; RATTUS; SCHISTOSOMA MANSONI; TREMATODA;

AUTACOID; CHOLINE; CYTOKINE; NUCLEOTIDE;

ANIMALS; BRAIN; CHOLINE; CYTOKINES; ECHINOSTOMA; ENERGY METABOLISM; FASCIOLA HEPATICA; FEMALE; HOST-PARASITE INTERACTIONS; INFLAMMATION MEDIATORS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; MODELS, STATISTICAL; NUCLEOTIDES; PHENOTYPE; RATS; RATS, WISTAR; SCHISTOSOMA MANSONI; SYSTEMS BIOLOGY; TIME FACTORS;

EID: 80053384041     PISSN: 17444292     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2010.49     Document Type: Article

References (56)

1. Ali EM (2008) Fasciola gigantica: purification and characterization of adenosine deaminase. Exp Parasitol 119: 285-290
2. Bax A, Davies DG (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 65: 355-360
3. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2: 2692-2703
4. Bell JD, Brown JC, Nicholson JK, Sadler PJ (1987a) Assignment of resonances for acute-phase glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett 215: 311-315
5. Bell JD, Sadler PJ, Macleod AF, Turner PR, La Ville A (1987b) 1H NMR studies of human blood plasma. Assignment of resonances for lipoproteins. FEBS Lett 219: 239-243
6. Bro R, Kjeldahl K, Smilde AK, Kiers HA (2008) Cross-validation of component models: a critical look at current methods. Anal Bioanal Chem 390: 1241-1251
7. Calder PC (2008) Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 52: 885-897
8. Calder PC (2009) Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 91: 791-795
9. Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J, Hudson J, Blancher C, Gauguier D, Lindon JC, Holmes E, Nicholson J (2005) Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal Chem 77: 1282-1289
10. Coen M, Lenz EM, Nicholson JK, Wilson ID, Pognan F, Lindon JC (2003) An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem Res Toxicol 16: 295-303
11. Crockford DJ, Holmes E, Lindon JC, Plumb RS, Zirah S, Bruce SJ, Rainville P, Stumpf CL, Nicholson JK (2006) Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem 78: 363-371
12. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikstrom C (2001) Multi and Megavariate Data Analysis Part I: Basic Principles and Applications. Umea, Sweden: Umetrics Academy
13. Ernst RRBG, Bodenhauser G, Wokaun A (1986) Principles of Nuclear Magnetic Resonance in One and Two Dimensions. Oxford: Clarendon
14. Fairweather I (2009) Triclabendazole progress report, 2005-2009: an advancement of learning? J Helminthol 83: 139-150
15. Foxall PJ, Parkinson JA, Sadler IH, Lindon JC, Nicholson JK (1993) Analysis of biological fluids using 600MHz proton NMR spectroscopy: application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment. J Pharm Biomed Anal 11: 21-31
16. Gounaris K (2002) Nucleotidase cascades are catalyzed by secreted proteins of the parasitic nematode Trichinella spiralis. Infect Immun 70: 4917-4924
17. Hasko G, Kuhel DG, Nemeth ZH, Mabley JG, Stachlewitz RF, Virag L, Lohinai Z, Southan GJ, Salzman AL, Szabo C (2000) Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 164: 1013-1019
18. Hasko G, Sitkovsky MV, Szabo C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 25: 152-157
19. Holmes E, Loo RL, Stamler J, Bictash M, Yap IKS, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P (2008a) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396-400
20. Holmes E, Tsang TM, Tabrizi SJ (2006) The application of NMR-based metabonomics in neurological disorders. NeuroRx 3: 358-372
21. Holmes E, Wilson ID, Nicholson JK (2008b) Metabolic phenotyping in health and disease. Cell 134: 714-717
22. Keiser J, Utzinger J (2009) Food-borne trematodiases. Clin Microbiol Rev 22: 466-483
23. Kreis R, Farrow N, Ross BD (1991) Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 4: 109-116
24. Lederberg J (2000) Infectious history. Science 288: 287-293
25. Li JV, Holmes E, Saric J, Keiser J, Dirnhofer S, Utzinger J, Wang Y (2009) Metabolic profiling of a Schistosoma mansoni infection in mouse tissues using magic angle spinning-nuclear magnetic resonance spectroscopy. Int J Parasitol 39: 547-558
26. Li JV,Wang Y, Saric J, Nicholson JK, Dirnhofer S, Singer BH, Tanner M, Wittlin S, Holmes E, Utzinger J (2008a) Global metabolic responses of NMRI mice to an experimental Plasmodium berghei infection. J Proteome Res 7: 3948-3956
27. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, Zhang Y, Shen J, Pang X,Wei H, Chen Y, Lu H, Zuo J, Su M, Qiu Y, JiaW, Xiao C, Smith LM, Yang S, Holmes E et al (2008b) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 105: 2117-2122
28. Li Z, Vance DE (2008) Phosphatidylcholine and choline homeostasis. J Lipid Res 49: 1187-1194
29. Liaudet L, Mabley JG, Pacher P, Virag L, Soriano FG, Marton A, Hasko G, Deitch EA, Szabo C (2002) Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Ann Surg 235: 568-578
30. Lim JH, Kim SY, Park CM (2007) Parasitic diseases of the biliary tract. Am J Roentgenol 188: 1596-1603
31. Mabley JG, Rabinovitch A, Suarez-Pinzon W, Hasko G, Pacher P, Power R, Southan G, Salzman A, Szabo C (2003) Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes. Mol Med 9: 96-104
32. Marcos LA, Terashima A, Gotuzzo E (2008) Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 21: 523-530
33. Marquardt DL, Parker CW, Sullivan TJ (1978) Potentiation of mast cell mediator release by adenosine. J Immunol 120: 871-878
34. Martin FPJ, Dumas ME, Wang Y, Legido-Quigley C, Yap IKS, Tang H, Zirah S, Murphy GM, Cloarec O, Lindon JC, Sprenger N, Fay LB, Kochhar S, van Bladeren P, Holmes E, Nicholson JK (2007) A topdown systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol 3: 112
35. Martin FPJ, Verdu EF, Wang Y, Dumas ME, Yap IKS, Cloarec O, Bergonzelli GE, Corthesy-Theulaz I, Kochhar S, Holmes E, Lindon JC, Collins SM, Nicholson JK (2006) Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. J Proteome Res 5: 2185-2193
36. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B (1993) Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248-250
37. Nicholls AW, Mortishire-Smith RJ, Nicholson JK (2003) NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol 16: 1395-1404
38. Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1: 153-161
39. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC (1995) 750MHz 1H and 1H-13CNMRspectroscopy of human blood plasma. Anal Chem 67: 793-811
40. Nicholson JK, Holmes E, Wilson ID (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 3: 431-438
41. Nicholson JK, Lindon JC, Holmes E (1999) Metabonomics understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189
42. Olde Damink SW, Deutz NE, Dejong CH, Soeters PB, Jalan R (2002) Interorgan ammonia metabolism in liver failure. Neurochem Int 41: 177-188
43. Parshad VR, Guraya SS (1977) Comparative histochemical observations on the excretory system of helminth parasites. Z Parasitenkd 52: 81-89
44. Pitman EJG (1938) Significance tests which may be applied to samples from any populations III. The analysis of variance test. Biometrika 29: 322-335
45. Ribeiro JM, Francischetti IM (2003) Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Annu Rev Entomol 48: 73-88
46. Saric J, Li JV, Wang Y, Keiser J, Bundy JG, Holmes E, Utzinger J (2008) Metabolic profiling of an Echinostoma caproni infection in the mouse for biomarker discovery. PLoS Negl Trop Dis 2: e254
47. Saric J, Li JV, Wang Y, Keiser J, Veselkov K, Dirnhofer S, Yap IKS, Nicholson JK, Holmes E, Utzinger J (2009) Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouse. J Proteome Res 8: 3899-3911
48. Schreiber G, Howlett G, Nagashima M, Millership A, Martin H, Urban J, Kotler L (1982) The acute phase response of plasma protein synthesis during experimental inflammation. J Biol Chem 257: 10271-10277
49. Tilley SL, Wagoner VA, Salvatore CA, Jacobson MA, Koller BH (2000) Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest 105: 361-367
50. Trygg J, Wold S (2002) Orthogonal projections to latent structures (OPLS). J Chemom 16: 119-128
51. Tsang TM, Haselden JN, Holmes E (2009) Metabonomic characterization of the 3-nitropropionic acid rat model of Huntingtons disease. Neurochem Res 34: 1261-1271
52. Veselkov KA, Lindon JC, Ebbels TM, Crockford D, Volynkin VV, Holmes E, Davies DB, Nicholson JK (2009) Recursive segment-wise peak alignment of biological (1)H NMR spectra for improved metabolic biomarker recovery. Anal Chem 81: 56-66
53. Wang Y, Utzinger J, Saric J, Li JV, Burckhardt J, Dirnhofer S, Nicholson JK, Singer BH, Brun R, Holmes E (2008) Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc Natl Acad Sci USA 105: 6127-6132
54. Zaki AE, Ede RJ, Davis M, Williams R (1984) Experimental studies of blood brain barrier permeability in acute hepatic failure. Hepatology 4: 359-363
55. Zaki AE, Wardle EN, Canalese J, Ede RJ, Williams R (1983) Potential toxins of acute liver failure and their effects on blood-brain barrier permeability. Experientia 39: 988-991
56. Zeisel SH, Mar MH, Howe JC, Holden JM (2003) Concentrations of choline-containing compounds and betaine in common foods. J Nutr 133: 1302-1307